Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens

Journal of Thoracic Oncology

Volumn 5, Issue 4, 2010, Pages 442-447

  Loo, Peh Sun ^a   Thomas, Stuart C ^a   Nicolson, Marianne C ^a   Fyfe, Margaret N ^a   Kerr, Keith M ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Bronchial biopsy diagnosis; Immunohistochemistry; Non small cell lung carcinoma; NSCLC subtype; NSCLC NOS; P63; Predictive value; TTF1; Undifferentiated carcinoma

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; MUCIN; PROTEIN P63; PSORIASIN; THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; BRONCHUS BIOPSY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

EID: 77950974826     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d40fac     Document Type: Article

References (37)

1. Burnett RA, Swanson Beck J, Howatson SR, et al. Observer variability in histopathological reporting of malignant bronchial biopsy specimens. J Clin Pathol 1994;47:711-713. (Pubitemid 24057749)
2. Rivera MP, Detterbeck F, Mehta AC. Diagnosis of lung cancer: the guidelines. Chest 2003;123:129-136. (Pubitemid 36135710)
3. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123(1 Suppl):115S-128S. (Pubitemid 36135709)
4. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med 2006;355: 2542-2550. (Pubitemid 44917502)
5. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
6. Travis WD, Brambilla E, Muller-Hermelink HK, et al. (Eds.) World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC press; 2004.
7. Burnett RA, Howatson SR, Lang S, et al. Observer variability in histopathological reporting of non-small cell carcinoma on bronchial biopsy specimens. J Clin Pathol 1996;49:130-133. (Pubitemid 26064918)
8. Thomas JS, Lamb D, Ashcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax 1993;48:1135-1139. (Pubitemid 23336832)
9. Edwards SL, Roberts C, McKean ME, et al. Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category. J Clin Pathol 2000;53:537-540. (Pubitemid 30432112)
10. Cataluña JJ, Perpiñá M, Greses JV, et al. Cell type accuracy of bronchial biopsy specimens in primary lung cancer. Chest 1996;109:1199-1203. (Pubitemid 26145656)
11. Matsuda M, Horai T, Nakamura S, et al. Bronchial brushing and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer. Thorax 1986;41:475-478. (Pubitemid 16089183)
12. Lyall MS, Chapman AD, Kerr KM. The diagnosis of lung cancer on bronchoscopic biopsy. CPD Bull Cell Path 2006;6:20-30. (Pubitemid 46099142)
13. Chuang MT, Marchevsky A, Teirstein AS, et al. Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax 1984;39:175-178. (Pubitemid 14154222)
14. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116:823-830. (Pubitemid 33108152)
15. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696-702. (Pubitemid 37051496)
16. Au NHC, Gown AM, Cheang M, et al. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunhistochem Mol Morphol 2004;12:240-247.
17. Shtilbans V, Szporn AH, Wu M, et al. P63 immunostaining in destained bronchoscopic cytological specimens. Diagn Cytopathol 2005;32:198-203. (Pubitemid 40397327)
18. Wu M, Szporn AH, Zhang D, et al. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol 2005;33:223-227. (Pubitemid 41368249)
19. Zhang H, Liu J, Cagle PT, et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol 2005;18:111-118. (Pubitemid 40128103)
20. Camilo R, Capelozzi Vl, Siqueira SA, et al. Expression of p63, keratin 5/6 and surfactant-A in non-small cell lung carcinomas. Hum Pathol 2006;37:542-546.
21. Kargi A, Gurel D, Tuna B. The diagnostic value of TTF-1, CK5/6 and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007;15:415-420. (Pubitemid 350307847)
22. Zhang H, Wang Y, Chen Y, et al. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. Lung Cancer 2007;57:37-45. (Pubitemid 46843348)
23. Zhang H, Zhao Q, Chen Y, et al. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 2008;63:352-359. (Pubitemid 351497949)
24. Khayyata S, Yun S, Pasha T, et al. Value of p63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol 2009;37:178-183.
25. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathol 2000;36:8-16. (Pubitemid 30055417)
26. Yatabe Y, Mitsudomi T, Takahashi T, et al. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 2002;26:767-772. (Pubitemid 34546942)
27. Stenhouse G, Fyfe N, King G, et al. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol 2004;57:383-387. (Pubitemid 38446256)
28. Looney CG. Pattern Recognition Using Neural Networks: Theory and Algorithms for Engineers and Scientists 1997. New York: Oxford University Press Inc.; 1997.
29. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 2006;19:1117-1123. (Pubitemid 44106727)
30. Pelosi G, Fraggetta F, Pasini F, et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 2001;25:363-372. (Pubitemid 32175139)
31. Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumours. Cancer Cytopathol 2004;102:109-114.
32. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 2003;34:597-604. (Pubitemid 36750372)
33. Rossi G, Marchioni A, Milani M, et al. TTF-1, cytokeratin 7, 34βE12 and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol 2004;122:884-893. (Pubitemid 39577356)
34. Kennedy A, Burgin PD. A comparison of different methods of detecting mucin in adenocarcinomas of the lung. Br J Dis Chest 1975;69:137-143.
35. Monica V, Ceppi P, Righi L, et al. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 2009;22:709-717.
36. Hirsch FR, Spreafico A, Novello S, et al. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 2008;3:1468-1481.
37. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361:947-957.